Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent
responsible for the COVID-19 pandemic, has outspread at full tilt across the world. Although …

During the early phase of the COVID-19 pandemic, many respiratory therapies were
classified as aerosol-generating procedures. This categorization resulted in a broad range …

Nebulisers are devices that reduce a body of liquid into a fine aerosol suitable for inhalation.
Utilising the efficiency of pulmonary drug absorption, they offer a safe and powerful modality …

Background The oral cavity can be a reservoir for SARS-CoV-2 and may play a crucial role
in the viral transmission in the hospital environment. Objective To investigate whether an …

Background Nebulizers are used commonly for inhaled drug delivery. Because they deliver
medication through aerosol generation, clarification is needed on what constitutes safe …

Nebulised therapy is the mainstay for treating obstructive airway diseases, but there is
heightened concern about the potential risk for SARS-CoV-2 transmission during …

In clinical practice, several emergencies may threaten the life of patients, and these
emergencies can be unpredictable and challenging. During the coronavirus disease 2019 …

Several lines of treatment for COVID-19 are being used worldwide, but to date, the perfect
line of therapy is not available. Nanomedicines received success rates in past in treating …

Early in COVID-19 pandemic, out-patient medical services were markedly curtailed. Many
pulmonary function laboratories were closed with the exception of tests deemed to be …

Nebulizers convert liquid medicines into a fine mist for inhalation, typically to treat a variety
of airway disorders, such as asthma, chronic obstructive pulmonary disease (COPD), and …